Zyversa Therapeutics (NASDAQ: ZVSA) reported Q4 2023 earnings per share (EPS) of $58.62, up N/A year over year. Total Zyversa Therapeutics earnings for the quarter were -$13.34 million. In the same quarter last year, Zyversa Therapeutics's earnings per share (EPS) was N/A.
As of Q2 2024, Zyversa Therapeutics's earnings has grown year over year. Zyversa Therapeutics's earnings in the past year totalled -$106.25 million.
What was ZVSA's revenue last quarter?
Zyversa Therapeutics (NASDAQ: ZVSA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Zyversa Therapeutics's revenue was N/A.
What was ZVSA's revenue growth in the past year?
As of Q2 2024, Zyversa Therapeutics's revenue has grown null year over year. Zyversa Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.